High-Sensitivity Cardiac Troponin—Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women (CODE-MI): Rationale and design for a multicenter, stepped-wedge, cluster-randomized trial

This publication has 38 references indexed in Scilit:

• Use of Medicare Data to Identify Coronary Heart Disease Outcomes in the Women’s Health Initiative
  Circulation: Cardiovascular Quality and Outcomes, 2014
• Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010
  European Heart Journal, 2013
• The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials
  PLOS Medicine, 2012
• Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population
  Clinical Chemistry, 2012
• When is informed consent required in cluster randomized trials in health research?
  Trials, 2011
• Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation
  Journal of Clinical Epidemiology, 2011
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials
  Circulation, 2011
• Sex Differences in Mortality After Acute Myocardial Infarction
  Archives of internal medicine (1960), 2009
• Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
  Heart, 2008
• Design and analysis of stepped wedge cluster randomized trials
  Contemporary Clinical Trials, 2007